Lakefront Biotherapeutics (LKFT) Revenue Growth (1y) (2015 - 2026)
Lakefront Biotherapeutics (LKFT) Revenue Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | - |
| 3 | Akari Therapeutics | 1,021.31 Bn | 1,021.31 Bn | - | - |
| 4 | BeOne Medicines | 467.89 Bn | 463.10 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 70.19 Bn | 61.44 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 63.46 Bn | 63.46 Bn | - | - |
| 8 | Argenx Se | 55.64 Bn | 50.45 Bn | 1.41 Bn | 64.03% |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | 96.43% |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.54 Bn | 1.91 Mn | -91.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -91.36% |
| Dec 31, 2025 | 7,733.23% |
| Sep 30, 2025 | -62.33% |
| Jun 30, 2025 | 227.60% |
| Mar 31, 2025 | 20.09% |
| Dec 31, 2024 | -89.76% |
| Sep 30, 2024 | 208.72% |
| Jun 30, 2024 | -185.24% |
| Mar 31, 2024 | 6.59% |
| Dec 31, 2023 | -37.87% |
| Sep 30, 2023 | 143.85% |
| Jun 30, 2023 | 185.99% |
| Mar 31, 2023 | 306.45% |
| Dec 31, 2022 | -20.82% |
| Sep 30, 2022 | 311.33% |
| Jun 30, 2022 | -84.98% |
| Mar 31, 2022 | -99.99% |
| Dec 31, 2021 | -56.95% |
| Sep 30, 2021 | -98.11% |
| Jun 30, 2021 | 40.35% |